Kazia Therapeutics Ltd ADR (KZIA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2015 | 06-2014 | 06-2013 | 06-2012 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,629 | -6,950 | -800 | -1,380 | -10,160 |
| Depreciation Amortization | 443 | 520 | 340 | 20 | 80 |
| Accounts receivable | -65 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,048 | N/A | N/A | N/A | N/A |
| Other Working Capital | 846 | 0 | -3,430 | 1,390 | 320 |
| Other Operating Activity | -1,079 | 1,190 | -5,140 | 630 | 420 |
| Operating Cash Flow | $-4,436 | $-5,240 | $-9,030 | $660 | $-9,340 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -69 | -20 | 140 | 6 | 300 |
| Net Acquisitions | N/A | 0 | 30 | 0 | 0 |
| Investing Cash Flow | $-69 | $-20 | $170 | $6 | $300 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 38,794 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -2,266 | 5,050 | 3,090 | 1,800 | 810 |
| Financing Cash Flow | $36,528 | $5,050 | $3,090 | $1,800 | $810 |
| Exchange Rate Effect | 233 | 0 | 0 | -60 | -760 |
| Beginning Cash Position | 1,928 | 2,510 | 8,570 | 5,950 | 15,160 |
| End Cash Position | 34,184 | 2,290 | 2,810 | 8,360 | 6,180 |
| Net Cash Flow | $32,256 | $-210 | $-5,760 | $2,400 | $-8,970 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,436 | -5,240 | -9,030 | 660 | -9,340 |
| Capital Expenditure | -75 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -4,511 | -5,240 | -9,030 | 660 | -9,340 |